Indicator Explainer
Hepatitis C Antibody
An antibody produced by B-lymphocytes in response to hepatitis C virus infection.
This page explains what the indicator is and how results are interpreted in general terms. Reference ranges depend on the laboratory, the method, and your own situation — no single “normal value” applies to everyone. This page is health information, not a diagnosis. For symptoms, treatment, or urgent concerns, contact a healthcare professional.
When it is tested
Source: National Cancer Institute, NCI Thesaurus 26.09d, C116400. NCI definition, reproduced without modification under CC BY 4.0. Source identity and definition checked automatically on 2026-10-19. No individual clinical interpretation or human reviewer is asserted.
Reading results
Reference intervals and interpretation depend on the laboratory, specimen, method and clinical context. This source definition is educational information; it does not establish a diagnosis, product approval or suitability for an individual.
Also Known As
References
- NCI Thesaurus 26.09d — Hepatitis C Antibody (C116400)
- Source: National Cancer Institute, NCI Thesaurus 26.09d, C116400. NCI definition, reproduced without modification under CC BY 4.0.
- Integrated Studies of Infectious Disease Elimination (InSIDE): Hepatitis C Antibody and RNA Status of Persons Who Inject Drugs in New York State, 2021-2023. — J Viral Hepat, 2026-08-01 (PMID 42426978; literature)
- Non-randomised trial of a hepatitis C same-day test and treat model using antibody test only for people who inject drugs in Armenia, Georgia and Tanzania: a CUTTS HepC study protocol. — BMJ Open, 2026-03-24 (PMID 41876153; literature)
- Comparative Analysis of Detection Capabilities for Hepatitis B Antibody, Hepatitis C Antibody, and Syphilis Antibody in Different Medical Institutions in Kaifeng, China. — Risk Manag Healthc Policy, 2025-09-10 (PMID 40959709; literature)
- Kidney transplantation from hepatitis C antibody-positive donors into hepatitis C-negative recipients: initial single-centre experience in the UK. — Br J Surg, 2025-08-01 (PMID 40827649; literature)
- Utilization of Organs from Hepatitis C-Antibody-Positive or RNA-Positive Donors in Kidney Transplantation: A Single-Center Retrospective Analysis of Outcomes and Safety. — J Clin Med, 2025-04-12 (PMID 40283483; literature)